MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Lymphoma Diagnosis and Treatment
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,251 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,251 works in the cohort · of 4,299,418page 31 of 66

Labels cover 5 of 3,251 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,251 of 3,251 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

fundno affno abstractunlabeled
Cell-secreted signals shape lymphoma identity
Annunziata Gloghini, Italia Bongarzone
2015· review· en· Seminars in Cancer Biology· Medicine
machine prediction:candidate · noneconsensus · none
8
citations
affunlabeled
Maxillofacial lymphomas
David MacDonald, Montgomery Martin, Kerry J. Savage
2020· review· en· British Journal of Radiology· Medicine
machine prediction:candidate · noneconsensus · none
8
citations
8
citations
affunlabeled
Randomised Intergroup Trial of First line Treatment for young Low-Risk Patients (<61 years) with Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL) with a CHOP-like Regimen with or without the Anti-CD20 Antibody Rituximab – 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group
Michael Pfreundschuh, Evelyn Kuhnt, Lorenz Trümper, Anders Österborg, Marek Trněný, Lois E. Shepherd +15 more
2010· article· en· Blood· Medicine
machine prediction:candidate · noneconsensus · none
8
citations
affno abstractunlabeled
Biomarkers and Prognosis in Malignant Lymphomas
Anton Hagenbeek, Randy D. Gascoyne, Martin Dreyling, Philip M. Kluin, Andreas Engert, Gilles Salles
2009· article· en· Clinical Lymphoma & Myeloma· Medicine
machine prediction:candidate · noneconsensus · none
7
citations
affunlabeled
Case 285: Primary Breast Lymphoma
Mona El Khoury, Antonio Maietta, Alphonse Tran, Isabelle Trop, Lucie Lalonde, Benoı̂t Mesurolle
2020· article· en· Radiology· Medicine
machine prediction:candidate · noneconsensus · none
7
citations

How this was built: Screen · Findings · About